Welcure Drugs & Pharmaceuticals Ltd — Others, 17-06-2025: AGM/EGM

The company has announced a board meeting to consider and approve the financial results for the quarter and half-year. This update signals the company’s ongoing compliance with financial reporting timelines, providing investors a forthcoming view on its operational performance and financial health. Shareholders can anticipate key financial metrics that will offer insights into business trends and profitability for the recent periods.